Recently, Vladimir Parpura, distinguished professor and director of the International Translational Neuroscience Research Institute (ITNRI) at Zhejiang Chinese Medical University (ZCMU) has been elected to the officer of the International Society for Neurochemistry (ISN). The ISN Officers consist of a president, secretary, and treasurer. It is learned that Professor Parpura is currently in charge of financial affairs as the alternate president and is poised to transition to the rotating president after two years. It is the first time that ZCMU’s high talent has assumed a core leadership role at an international academic institution, which not only recognizes Professor Parpura’s academic achievements and management capabilities, but also highlights his vital influence in the international neuroscience community. In his role as a key decision maker of ISN, Professor Parpura will contribute to shaping the global neurochemistry development strategy, drive the consolidation of academic resources and strengthen multinational collaboration. His appointment is expected to elevate ZCMU’s scholarly leadership in this discipline and foster its integration into the global neuroscience innovation network.

Established in 1965, ISN is a leading global authority advancing molecular and cellular neuroscience through interdisciplinary collaboration. ISN drives cutting-edge research in the field through its flagship journal, Journal of Neurochemistry, which ranks among the top 25% in neuroscience and 20% in biochemistry and molecular biology. With more than 37,000 annual citations, the journal serves as a premier global platform for disseminating pioneering discoveries in neurochemistry.

Professor Vladimir Parpura, a leading figure in global neuroscience, holds memberships in the Academia Europaea and Slovenian Academy of Science and Arts, and fellowships in the American Association for the Advancement of Science (AAAS) and American Physiological Society. As ZCMU’s key international recruit, Professor Parpura and his team are absorbed in cutting-edge investigations into neurobiology mechanisms centered on “gliotransmitters.” Their work focuses on decoding the mechanism of “abnormal glioma exocytosis” in brain diseases like glioblastoma and the conversion therapy of integrated traditional Chinese and Western medicine.